Literature DB >> 11706108

Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland.

M Hiltunen1, A Mannermaa, D Thompson, D Easton, M Pirskanen, S Helisalmi, A M Koivisto, M Lehtovirta, M Ryynänen, H Soininen.   

Abstract

BACKGROUND: AD is a complex neurodegenerative disorder comprising several disease-associated chromosome loci. To find novel susceptibility genes for late-onset AD, a population-based genome-wide search using linkage disequilibrium (LD) mapping approach has been performed.
METHOD: Forty-seven patients with late-onset AD and 51 age-matched control subjects were carefully chosen from the same geographic area in eastern Finland, where the population is descended mainly from a small group of original founders. These subjects were initially genotyped with 366 polymorphic microsatellite markers, and a follow-up analysis was performed with additional microsatellite markers for those chromosome loci found to be associated with AD.
RESULTS: Initial genome-wide screening revealed 21 chromosomal loci significantly associated with AD in addition to the 13q12 locus described previously. Subsequent comparison of single-allele frequencies of the microsatellite markers in the AD and control groups indicated the presence both of possible risk alleles (odds ratio [OR] > 1) and of possible protective alleles (OR < 1). Screening of the LD regions with additional microsatellite markers revealed seven chromosomal loci where more than one microsatellite marker was associated with AD (1p36.12, 2p22.2, 3q28, 4p13, 10p13, 18q12.1, and 19p13.3) in addition to the 13q12 locus.
CONCLUSIONS: These genome-wide LD screening data suggest that several AD-associated chromosomal loci exist, which may encompass novel susceptibility genes for late-onset AD. Therefore, extensive screening of the genes located in the vicinity of these LD regions is necessary to elucidate their role in AD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11706108     DOI: 10.1212/wnl.57.9.1663

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  29 in total

1.  Evidence for three loci modifying age-at-onset of Alzheimer's disease in early-onset PSEN2 families.

Authors:  Elizabeth E Marchani; Thomas D Bird; Ellen J Steinbart; Elisabeth Rosenthal; Chang-En Yu; Gerard D Schellenberg; Ellen M Wijsman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-07       Impact factor: 3.568

2.  A genome-wide linkage analysis of dementia in the Amish.

Authors:  Daniel W Hahs; Jacob L McCauley; Amy E Crunk; Lynne L McFarland; Perry C Gaskell; Lan Jiang; Susan H Slifer; Jeffery M Vance; William K Scott; Kathleen A Welsh-Bohmer; Stephanie R Johnson; Charles E Jackson; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-03-05       Impact factor: 3.568

3.  New Alzheimer's disease locus on chromosome 8.

Authors:  V Giedraitis; M Hedlund; L Skoglund; E Blom; S Ingvast; R Brundin; L Lannfelt; A Glaser
Journal:  J Med Genet       Date:  2006-07-06       Impact factor: 6.318

4.  Genome scan of age-at-onset in the NIMH Alzheimer disease sample uncovers multiple loci, along with evidence of both genetic and sample heterogeneity.

Authors:  Yoonha Choi; Elizabeth E Marchani; Thomas D Bird; Ellen J Steinbart; Deborah Blacker; Ellen M Wijsman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-08-02       Impact factor: 3.568

5.  Functional and structural analysis of the conserved EFhd2 protein.

Authors:  Yancy Ferrer-Acosta; Eva N Rodríguez Cruz; Ana del C Vaquer; Irving E Vega
Journal:  Protein Pept Lett       Date:  2013-05       Impact factor: 1.890

6.  Somatostatin genetic variants modify the risk for Alzheimer's disease among Finnish patients.

Authors:  Saila Vepsäläinen; Seppo Helisalmi; Anne M Koivisto; Toni Tapaninen; Mikko Hiltunen; Hilkka Soininen
Journal:  J Neurol       Date:  2007-11-09       Impact factor: 4.849

Review 7.  Genomic variants, genes, and pathways of Alzheimer's disease: An overview.

Authors:  Adam C Naj; Gerard D Schellenberg
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

8.  Beyond proof of principle: new genes for Alzheimer's disease through collaboration.

Authors:  Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Lancet Neurol       Date:  2009-11       Impact factor: 44.182

9.  Genetic variation in apolipoprotein D and Alzheimer's disease.

Authors:  Seppo Helisalmi; Mikko Hiltunen; Saila Vepsäläinen; Susan Iivonen; Elizabeth H Corder; Maarit Lehtovirta; Arto Mannermaa; Anne Maria Koivisto; Hilkka Soininen
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

10.  Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22.

Authors:  William K Scott; Elizabeth R Hauser; Donald E Schmechel; Kathleen A Welsh-Bohmer; Gary W Small; Allen D Roses; Ann M Saunders; John R Gilbert; Jeffery M Vance; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Am J Hum Genet       Date:  2003-10-16       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.